Immunogenicity and Safety of Concomitant Administration of a Combined Hepatitis A/B Vaccine and a Quadrivalent Meningococcal Conjugate Vaccine in Healthy Adults
Author(s) -
Martin Alberer,
Gerd Burchard,
Tomáš Jelı́nek,
Emil C. Reisinger,
Seetha Meyer,
Eduardo ForleoNeto,
Alemnew F. Dagnew,
Ashwani Kumar Arora
Publication year - 2014
Publication title -
journal of travel medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.985
H-Index - 59
eISSN - 1708-8305
pISSN - 1195-1982
DOI - 10.1111/jtm.12180
Subject(s) - medicine , immunogenicity , vaccination , hepatitis b , hepatitis a , immunology , booster dose , hepatitis b vaccine , conjugate vaccine , immunization , concomitant , hepatitis , virology , hepatitis b virus , antibody , hbsag , virus
This phase 3b randomized, open-label study evaluated the immunogenicity and safety of coadministration of a hepatitis A and/or B vaccine with a quadrivalent oligosaccharide meningococcal CRM197 -conjugate vaccine (MenACWY-CRM), in the context of an accelerated hepatitis A and/or B immunization schedule.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom